Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
boston blog main
clinical trials
digital health
fda
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
akcea therapeutics
akili interactive labs
alnylam pharmaceuticals
andrew fire
biologic drugs
biotech
boston
boston top stories
boston xcon
boulder/denver xcon
bruce leuchter
click therapeutics
clickotine
craig mello
david benshoof klein
david klein
detroit xcon
digital medicines
digital therapeutics
drug development
genome sequencing
healthtech
hereditary transthyretin amyloidosis
indiana xcon
innovation
inotersen
john maraganore
joshua steinerman
national xcon
new york
What
drug
3
×
making
3
×
medicine
3
×
medicines
afternoon
alnylam
alnylam’s
announced
approved
backs
bets
biologic
bottleneck
click
clinical
development
digital
dramatically
example
fda
field
fixing
gain
genomic
gets
grabbed
history
landmark
latest
makers
momentum
monday
nascent
ok
onpattro
past
patients
patisiran
pharmaceuticals
priority
Language
Current search:
xconomy.com
×
medicine
×
making
×
drug
×
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@xconomy.com
6 years ago
Fixing the Clinical Trial Bottleneck by Making Patients a Priority
